TAM (Treatments and Medicines) NHS Highland
Poster:
Author is aware that the guidance on TAM is due for review and plans to review this Winter 2025/26. The guidance can continue to be used in this interim period. If you have any queries, please contact the guideline authors.
Children (Antimicrobial)
Warning
What's new / Latest updates
16/09/24: Out of date information removed re Group A Strep
A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments.
Clinical judgement should be exercised on the applicability of any guideline, influenced by individual patient characteristics. Clinicians should be mindful of the potential for harmful polypharmacy and increased susceptibility to adverse drug reactions in patients with multiple morbidities or frailty.
If, after discussion with the patient or carer, there are good reasons for not following a guideline, it is good practice to record these and communicate them to others involved in the care of the patient.